Package Insert: Information for the User
Fluoxetina Viatris 20 mg Dispersible Tablets EFG
Fluoxetine Hydrochloride
Read this package insert carefully before starting to take this medication, as it contains important information for you.
6. Contents of the pack and additional information
This medication is indicated for the treatment of:
Adults:
Children over 8 years and adolescents:
For moderate to severe depressive episodes, if there is no response to psychological therapy after4 to6 sessions. Fluoxetina should be offered to children or young people with moderate to severe depression only in combination with a psychological therapy.
How fluoxetina works
Every person has a substance called serotonin in their brain. People who are depressed or have obsessive-compulsive disorder or bulimia nervosa have lower levels of serotonin than others. The exact way fluoxetina and other SSRIs work is not fully understood, but they may help by increasing serotonin levels in the brain.
Treating these conditions is important to help improve. If not treated, your condition cannot disappear and may become more severe and difficult to treat.
You may need to be treated for a few weeks or months to ensure you are free of symptoms.
Do not take Fluoxetina Viatris
The treatment with fluoxetine may only be initiated after 2 weeks of completing a treatment with an irreversible non-selective MAO inhibitor (for example, tranilcipromina).non-selectiveMAO inhibitor.
Do not take any irreversible non-selective MAO inhibitor for at least 5 weeks after stopping fluoxetine medication. If you have been prescribed fluoxetine for a long period of time and/or at a high dose, your doctor may consider the need to establish a longer interval before taking an MAO inhibitor. Examples of MAOIs include nialamide, iproniazid, selegiline, moclobemide, phenelzine, tranilcipromina, isocarboxazid, and toloxatone.
Warnings and precautions
Consult your doctor or pharmacist before starting to take fluoxetine:
Thoughts of suicide and worsening of your depression or anxiety
If you are depressed and/or have an anxiety disorder, you may have thoughts of self-harm or suicide. This may increase when starting to take antidepressants, as all these medications take time to start working, usually around 2 weeks, although in some cases it may take longer.
You may be more likely to have these thoughts:
-If you have previously had thoughts of self-harm or suicide.
-If you are a young adult. Information from clinical trials has shown an increased risk of suicidal behavior in adults under 25 years with psychiatric disorders treated with antidepressants.
If you have any thoughts of self-harm or suicide, contact your doctor or go directly to the hospital.
It may be helpful for you to tell a family member or close friendthat you are depressed or have an anxiety disorder and ask them to read this leaflet. You can ask them if they think your depression or anxiety has worsened or if they are concerned about changes in your behavior.
Children and adolescents
Patients under 18 years old have a higher risk of adverse effects, such as attempts at suicide, suicidal thoughts, and hostility (primarily aggression, confrontational behavior, and irritability) when taking this class of medications. Fluoxetine should only be used in children and adolescents from 8 to 18 years old for the treatment of moderate to severe depressive episodes in combination with psychological therapy and should not be used for other indications in this age group.
Additionally, there is only limited information regarding the long-term safety of fluoxetine in relation to growth, puberty, and cognitive, emotional, and behavioral development in this age group. However, if you are a patient under 18 years old, your doctor may prescribe fluoxetine for the treatment of moderate to severe depressive episodes in combination with psychological therapy when they decide it is in the best interest of the patient. If your doctor prescribes fluoxetine to a patient under 18 years old and you wish to discuss this decision, please return to your doctor. You should inform your doctor if any of the symptoms indicated above appear or worsen when patients under 18 years old are taking fluoxetine.
Fluoxetine should not be used in children under 8 years old.
Other medications and Fluoxetine Viatris
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.
Do not take Fluoxetine Viatris with:
Fluoxetine may interact with other medications (interaction):
Taking Fluoxetine Viatris with food, drinks, and alcohol
If you are pregnant or breastfeeding, or if you think you may be pregnant, consult your doctor or pharmacist before taking this medication.
Pregnancy
Infants whose mothers took fluoxetine during the first months of pregnancy have had some studies describing an increased risk of congenital heart defects. In the general population, approximately 1 in 100 babies are born with a heart defect. This figure increased to around 2 in 100 babies of mothers who took fluoxetine.
When taken during pregnancy, especially in the last 3 months of pregnancy, medications like fluoxetine may increase the risk of a serious condition in newborns, called persistent pulmonary hypertension of the newborn (PPHN), which causes the baby to breathe faster and turn blue. These symptoms usually begin within the first 24 hours after the baby is born. If this happens to your baby, contact your midwife and/or doctor immediately.
Fluoxetine taken in the final stages of pregnancy may increase the risk of excessive bleeding after delivery, especially if you have a history of bleeding disorders. Your doctor or midwife should know that you are taking fluoxetine to advise you.
It is preferable not to use this treatment during pregnancy unless the potential benefit outweighs the potential risk. Therefore, you and your doctor may decide to gradually stop taking fluoxetine during pregnancy or before becoming pregnant. However, depending on your circumstances, your doctor may suggest that it is better for you to continue taking fluoxetine.
Caution should be exercised when taking fluoxetine during pregnancy, especially in the last stage of pregnancy or just before delivery, as there have been reports of the following effects in newborns: irritability, tremors, muscle weakness, persistent crying, difficulty breastfeeding, or difficulty sleeping.
Lactation
Fluoxetine is excreted in breast milk and may cause adverse effects in infants. You should only continue breastfeeding if absolutely necessary. If you continue breastfeeding, your doctor may prescribe a lower dose of fluoxetine.
Fertility
Studies in animals have shown that fluoxetine reduces sperm quality.Reports in humans with certain SSRIs have shown that the effect on sperm quality is reversible.
Theoretically, this may affect fertility, but there has been no observed impact on human fertility.
Driving and operating machinery
Medications like fluoxetine can affect your judgment or coordination. Do not drive or operate machinery until you know how fluoxetine affects you.
Fluoxetine Viatris contains sodium
This medication contains less than 1 mmol of sodium (23 mg) per tablet; it is essentially "sodium-free."
Swallow the tablets with half a glass of water or dissolved in half a glass of water, which must be swallowed immediately and completely. Do not chew them.
Adults:
The recommended dose is:
Your doctor may review and adjust the dose after two weeks of treatment. When necessary, the dose can be increased gradually up to a maximum of 3 tablets (60 mg) per day. If no improvement is observed in the 10 weeks following, your doctor will reconsider your treatment.
Children and adolescents aged 8 to 18 years with depression:
Treatment should be initiated and supervised by a specialist. The initial dose is 10 mg/day (administered as 2.5 ml of a fluoxetine oral solution). After one or two weeks, your doctor may increase the dose to 20 mg/day. The dose should be increased carefully to ensure that you receive the minimum effective dose. Children with low weight may require lower doses. If there is a satisfactory response to treatment, your doctor should reevaluate the need to continue treatment after 6 months. If you have not improved in 9 weeks, treatment should be reconsidered.
Older patients:
The dose increases made by your doctor should be carried out more carefully, and the daily dose should not generally exceed 2 tablets (40 mg). The maximum dose is 3 tablets (60 mg) per day.
Patients with liver problems:
If you have a liver problem or are taking another medication that may affect fluoxetine, your doctor will decide to prescribe a lower dose or instruct you on how to take fluoxetine on alternate days.
If you take more Fluoxetina Viatris than you should:
In case of overdose or accidental ingestion, go to the emergency department of the nearest hospital, consult your doctor or pharmacist immediately, orcallthe Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount ingested. If possible, bring the packaging of Fluoxetina Viatris with you.
The symptoms of overdose include: nausea, vomiting, convulsions, cardiac problems (such as irregular heartbeats or cardiac arrest), respiratory problems, and changes in mental state ranging from excitement to coma.
If you forgot to take Fluoxetina Viatris:
If you interrupt treatment with Fluoxetina Viatris:
You may experience the following effects (withdrawal effects) when interrupting treatment with fluoxetine: dizziness, a sensation of pins and needles, sleep disturbances (intense dreams, nightmares, insomnia), a feeling of restlessness or agitation, unusual fatigue or weakness, anxiety, nausea and/or vomiting (feeling sick or being sick), tremors (unsteadiness), and headaches.
Most people find that the symptoms that occur when stopping treatment with fluoxetine are moderate and disappear within a few weeks. If you experience these symptoms when stopping your treatment, consult your doctor.
When stopping treatment with fluoxetine, your doctor will help you gradually reduce the dose over one to two weeks - this will help reduce the likelihood of withdrawal effects.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
The most common side effects (very common side effects that can affect more than 1 in 10 people) are insomnia, headache, diarrhea, discomfort (nausea) and fatigue.
Some patients have experienced:
If you experience any of the side effects described above, inform your doctor immediately.
The following side effects have also been reported in patients taking fluoxetine:
Frequent(can affect up to 1 in 10 people)
Rare(can affect up to 1 in 100 people)
Rare(can affect up to 1 in 1,000 people)
Unknown frequency(cannot be estimated from available data)
Fractures:in patients taking this type of medication, an increased risk of bone fractures has been observed.
Most of these side effects tend to disappear with continued treatment.
Other side effects in children and adolescents (8 to 18 years)
In addition to those mentioned above, fluoxetine may slow down growth or delay sexual maturation. Suicidal behaviors (suicide attempts and suicidal thoughts), hostility, mania, and nasal bleeding have also been frequently reported in children.
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Vigilance of Medicinal Products for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not usethis medicationafter the expiration date that appears on the blister pack and on the cardboard box after “CAD” or “EXP”. The expiration date is the last day of the month indicated.
This medicationdoes not require special storage conditions.
Medications should not be disposed of through drains or in the trash. Dispose of the packaging and medications you no longer need at the SIGRE collection pointof the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. In this way, you will help protect the environment.
Composition of Fluoxetina Viatris
The active ingredient is fluoxetine in the form of fluoxetine hydrochloride.
The other components are: microcrystalline cellulose, cornstarch, crospovidone, anhydrous colloidal silica, magnesium stearate, sodium saccharin, and peppermint powder.
Appearance of the product and content of the container
They are white, convex, oval-shaped dispersible tablets marked with FL/20 on one side and G on the other, presented in containers containing 14, 28, or 500 dispersible tablets.
Only some container sizes may be commercially marketed.
Marketing authorization holder
Viatris Pharmaceuticals, S.L.U.
C/ General Aranaz, 86
28027 - Madrid
Spain
Responsible for manufacturing
McDermott Laboratories Ltd. t/a Gerard Laboratories
310/36 Baldoyle Industrial Estate, Grange Road
Dublín 13
Ireland
Or
Mylan Hungary Kft
Mylan utca 1
2900 Komárom
Hungary
Last review date of this leaflet:July 2023
The detailed information of this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)(https://www.aemps.gob.es/)
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.